The RIGHT Foundation and EuBiologics Collaborate to Eradicate Meningococcal Disease in Africa
Hani Kim (from left), CEO of the Right Foundation; Seanette Wilson, Senior Project Manager at Biovac; Young-Ok Baik, CEO of EuBiologics; and Richard Gordon, Head of International Business Development at SAMRC, pose during a conference held at Songdo Convensia. 21 November 2024 The RIGHT Foundation, a global health technology research fund, and EuBi...
The RIGHT Foundation has decided to support Rapigen’s malaria diagnostic kit project.
13 October 2024 The RIGHT Foundation has decided to support Rapigen’s malaria diagnostic kit project. Rapigen brings its expertise in black gold nanoparticle technology, which enhances the sensitivity of malaria mutation detection. RIGHT Foundation’s backing will help Rapigen further develop and distribute this technology. Clinical trials are...
ArirangTV ‘Korea-Africa Summit Special LIVE Talk with The Globalists’
5 June 2024 The discussion focused on the key agendas of the Korea-Africa Summit, including ‘Energy, Health, Youth, and Startups,’ featuring experts from each field. Timothy Dickens, Chairman of the South African Chamber of Commerce in Korea, presented energy cooperation and investment strategies between Korea and Africa. Lee Hoon-sang,...
Neglected diseases affect one billion people worldwide. To eliminate them, Korea has a crucial role to play
By Dr Luis Pizarro, Executive Director of DNDi Dr Luis Pizarro is the Executive Director of the Drugs for Neglected Diseases initiative (DNDi), an international medical research non-profit organization that delivered 13 new treatments since its creation 20 years by Doctors Without Borders, the Institut Pasteur and the WHO. DNDi has offices in eight...
Could this trailblazing ODA strategy spark a new approach to global health? Experts discuss future perspectives on Korea’s ODA for global health
22 November 2023 In recent years, the conversation surrounding Official Development Assistance (ODA) from South Korea has gained significant momentum. As Korea positions itself as a crucial player in the international arena, its contributions to global health through ODA have become a topic of much interest. Korea’s involvement in global heal...
RIGHT Foundation commits additional 11.3 billion KRW to innovative infectious disease R&D projects for global public health
RIGHT Foundation commits additional 11.3 billion KRW to innovative infectious disease R&D projects for global public health RIGHT Foundation (Research Investment for Global Health Technology Foundation) has announced the recipients of its Product Development Award and the Evidence Generation Award from the 2022 Request for Proposals (RFP). Th...
RIGHT Foundation, BMGF, FIND come together to achieve health equity with Korean companies
9 June 2023 Global health experts emphasized the importance of derisking and incentivizing R&D for ensuring effective delivery and access to vaccines and diagnostics at the RIGHT Foundation’s fifth-anniversary forum in Seoul on Friday. FIND’s Executive Vice President of External Affairs Willo Brock (left) and RIGHT Foundation CEO Hani Kim show...
South Korean partners come together at the re-imagining TB initiative’s first collaboration workshop
13 December 2022 South Korean partners come together at the Re-imagining TB Care initiative’s first Collaboration Workshop to leverage their strength in R&D and health technologies for TB services Over 60 South Korean academic/research institutions, civil society, developers (multinationals, small- and medium-size enterprises (SMEs), start-ups...
RIGHT Fund opens its first Request for Proposal for 2022
This article is only available in Korean. Original Article Press Release List
Featured News: RIGHT Fund to receive research proposals for infectious disease
30 June 2022 The RIGHT (Research Investment for Global Health Technology) Fund said Thursday that it opened this year’s first request for proposals for Product Development Award (PDA) and Evidence Generation Award (EGA). It would receive them until Aug. 16. Both awards are research grants to support infectious disease researches to alleviate global...
Interview: Peter Hotez, Director of the RIGHT Fund “Inequity, the hidden super transmitter of COVID-19”
Interview: Peter Hotez, Director of the RIGHT Fund “Inequity, the hidden super transmitter of COVID-19” 15 February 2021 Published in Kukmin Ilbo This article is only available in Korean. Original Article News List
RIGHT Fund commits additional 13.6 billion KRW to innovative infectious disease R&D projects
RIGHT Fund (CEO Younbeen Kim / Research Investment for Global Health Technology Fund) has announced its selection of 2021 research grant award recipients for an additional funding of 13.6 billion KRW. The RIGHT Fund is a global health research funding foundation established in 2018 through the public-private partnership between the Ministry of He...
Taking equal accessibility and virus variants into consideration in prioritizing vaccine R&D
This article is only available in Korean. Original Article Press Release List
Column: Bora Kim, Program Associate of RIGHT Fund “Korea needs to grow interest in global public health market further”
15 February 2021 Published in the Korea Biomedical Review & the Korean Doctors’ Weekly Bora Kim, Program Associate of Investment Management Team, RIGHT Fund Global health is a growing priority for Korea’s international cooperation agenda as the COVID-19 pandemic has highlighted its well-executed pandemic response, providing opportunities for in...
Interview: Myongsei Sohn, Chairman of the Board of Directors, RIGHT Fund “Support for Infectious Disease R&D Should Aim to Prepare for Future Disasters rather than an Immediate Result”
21 January 2021 Published in the Joongang daily This article is only available in Korean. Original Article News List
Interview: Myongsei Sohn, Chairman of the Board of Directors, RIGHT Fund “No reasons to reject post that can enhance Korea’s healthcare status”
20 January 2021 Published in the Korea Biomedical Review & the Korean Doctors’ Weekly Former Yonsei University Professor Sohn Myong-sei, who served as director of the Health Insurance Review and Assessment Service, has taken office as the second chairman of the Research Investment for Global Health Technology (RIGHT) Fund. RIGHT Fund is an inte...
KT Joins RIGHT Fund as new industrial funder
This article is only available in Korean. Original Article Press Release List
Interview: Myongsei Sohn, Chairman of the Board of Directors, RIGHT Fund “Korea’s Advanced Medical Technology Becomes Now the Hope of Developing Countries”
20 January 2021 Published in the Yonsein monthly This article is only available in Korean. Original Article News List